LumiraDx Analyst Ratings
LumiraDx Analyst Ratings
While ratings are subjective and will change, the latest LumiraDx (LMDX) rating was a maintained with a price target of $4.00 to $3.50. The current price LumiraDx (LMDX) is trading at is $1.07, which is out of the analyst's predicted range.| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/11/2022 | 227.1% | Raymond James | $4 → $3.5 | Maintains | Outperform |
| 08/19/2022 | 273.83% | BTIG | $7 → $4 | Maintains | Buy |
| 08/19/2022 | 273.83% | Raymond James | $7 → $4 | Maintains | Outperform |
| 05/12/2022 | 1208.41% | Ladenburg Thalmann | $15.25 → $14 | Maintains | Buy |
| 05/12/2022 | 554.21% | Raymond James | $9 → $7 | Maintains | Outperform |
| 03/11/2022 | 741.12% | Raymond James | $13 → $9 | Maintains | Outperform |
| 11/15/2021 | 1769.16% | Evercore ISI Group | → $20 | Initiates Coverage On | → Outperform |
| 10/25/2021 | 1114.95% | Raymond James | → $13 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变动 | 评级变动 | 之前/当前的评级 |
|---|---|---|---|---|---|
| 11/11/2022 | 227.1% | 雷蒙德·詹姆 | 4 美元 → 3.5 美元 | 维护 | 跑赢大盘 |
| 2022 年 8 月 19 日 | 273.83% | BTIG | 7 美元 → 4 美元 | 维护 | 买 |
| 2022 年 8 月 19 日 | 273.83% | 雷蒙德·詹姆 | 7 美元 → 4 美元 | 维护 | 跑赢大盘 |
| 05/12/2022 | 1208.41% | 拉登堡塔尔曼 | 15.25 美元 → 14 美元 | 维护 | 买 |
| 05/12/2022 | 554.21% | 雷蒙德·詹姆 | 9 美元 → 7 美元 | 维护 | 跑赢大盘 |
| 03/11/2022 | 741.12% | 雷蒙德·詹姆 | 13 美元 → 9 美元 | 维护 | 跑赢大盘 |
| 11/15/2021 | 1769.16% | Evercore ISI 集团 | → 20 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
| 2021 年 10 月 25 日 | 1114.95% | 雷蒙德·詹姆 | → 13 美元 | 启动覆盖范围开启 | → 跑赢大盘 |
LumiraDx Questions & Answers
LumiRadX 问题与解答
The latest price target for LumiraDx (NASDAQ: LMDX) was reported by Raymond James on November 11, 2022. The analyst firm set a price target for $3.50 expecting LMDX to rise to within 12 months (a possible 227.10% upside). 7 analyst firms have reported ratings in the last year.
雷蒙德·詹姆斯于2022年11月11日公布了LumiRadX（纳斯达克股票代码：LMDX）的最新目标股价。该分析公司将目标股价定为3.50美元，预计LMDX将在12个月内升至12个月内（可能上涨227.10％）。去年有7家分析公司公布了评级。
The latest analyst rating for LumiraDx (NASDAQ: LMDX) was provided by Raymond James, and LumiraDx maintained their outperform rating.
LumiRadX（纳斯达克股票代码：LMDX）的最新分析师评级由雷蒙德·詹姆斯提供，LumiRadX维持跑赢大盘评级。
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of LumiraDx, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for LumiraDx was filed on November 11, 2022 so you should expect the next rating to be made available sometime around November 11, 2023.
分析师在进行了广泛的研究后得出了股票评级，其中包括浏览公开财务报表，与LumiRadx的高管和客户交谈，以及听取财报电话会议。大多数分析师每三个月做一次这样的评级，因此每家公司每年应该获得4次评级。LumiRadx的最新评级是在2022年11月11日公布的，因此您应该预计下一个评级将在2023年11月11日左右公布。
While ratings are subjective and will change, the latest LumiraDx (LMDX) rating was a maintained with a price target of $4.00 to $3.50. The current price LumiraDx (LMDX) is trading at is $1.07, which is out of the analyst's predicted range.
尽管评级是主观的，并且会发生变化，但最新的LumiRadX（LMDX）评级保持不变，目标股价为4.00美元至3.50美元。LumiRadX（LMDX）目前的交易价格为1.07美元，超出了分析师的预期区间。
